Dr. Arnaldo N. Da Silva, MD

Dr. Da Silva practices at Palm Beach Neurology in West Palm Beach, Florida.

Dr. Da Silva's NPI, 1801004841, was assigned on May 21, 2007. Dr. Da Silva graduated from Pritzker School of Medicine in 1988. Dr. Da Silva's Michigan license number on file is 4301085497.

Dr. Da Silva's primary practice is Palm Beach Neurology, at 4631 N Congress Ave, West Palm Beach, FL 33407 in Palm Beach County. The practice phone is (561) 845-0500.

Dr. Da Silva's primary practice is Palm Beach Neurology in West Palm Beach, Florida. Dr. Da Silva is also affiliated with Jupiter Medical Center. The medical group on file is Palm Beach Neurology and Premiere Research Institute. Dmand AI also links Dr. Da Silva to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Da Silva practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Da Silva's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Da Silva is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Da Silva's licenses on file in 6 states: Michigan, Florida, Colorado, Illinois, Ohio and Virginia.

Dmand AI lists acute mini-stroke (TIA), encephalopathy, head injury, migraine and chronic headache and thoracic spine disorders among the conditions Dr. Da Silva treats.

CMS data shows 71,751 Medicare services from Dr. Da Silva across 6 procedure codes in 2024, for 274 Medicare patients. Medicare paid $474,330 for them. Every service was in an office.

CMS counts 274 Medicare patients who saw Dr. Da Silva in 2024. The largest group is 65 to 74, with 135 patients. 75% of them have high cholesterol, and 66% have arthritis. 4% are also on Medicaid. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Da Silva's median patient age at 56, with 78% women.

In 2024, Dr. Da Silva wrote 2,031 Medicare Part D claims for 291 patients. 54% of them were for generic drugs. CMS names the drug for 1,779 of them, across 31 drugs with 11 or more claims each, at $1,008,837 in total drug cost. In 2023, CMS named 1,464 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Da Silva for performance year 2024, reported as part of a group. Dr. Da Silva accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Da Silva as offering telehealth.

Dmand AI links 13 papers to Dr. Da Silva, published from 2006 to 2025. The most frequent topics are Brain Neoplasms, Analgesics and Headache. Dr. Da Silva has published most often in CNS Drugs. Dr. Da Silva's most frequent co-authors are Stewart J. Tepper, MD, Badih A. Adada, MD and Anam Baig.

CMS Open Payments shows 1,111 general payments to Dr. Da Silva from 62 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 70% of the total. Amgen Inc. paid the most, $54,617.

Dr. Da Silva graduated from Pritzker School of Medicine in 1988.

Dr. Da Silva is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.